X-Site Seeks Financing, Possible Partner For Vascular Closure System Launch
This article was originally published in The Gray Sheet
X-Site Medical is pursuing additional financing to support commercialization of its recently approved X-Press 6 Fr. vascular closure system
You may also be interested in...
Abbott believes its StarClose vascular closure device will represent a competitive alternative to St. Jude's market leading AngioSeal upon U.S. approval in 2005
The companies think they can build out the indications for zuranalone and SAGE-324 faster and more broadly and commercialize the drugs more effectively as partners.